JOINN Laboratories (China) Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004BP3
HKD
19.86
5.06 (34.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
356.74
737.86
345.72
411.35
307.21
738.81
528.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
356.74
737.86
345.72
411.35
307.21
738.81
528.62
Raw Material Cost
283.65
606.63
301.74
336.23
228.74
527.86
422.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.31
0.38
0.33
0.28
0.56
0.67
0.63
Selling and Distribution Expenses
85.47
79.57
87.85
74.76
64.65
63.62
88.33
Other Expenses
2.17
2.31
1.96
1.98
2.21
2.07
2.24
Total Expenditure (Excl Depreciation)
391.09
709.65
409.52
431.04
316.06
612.88
534.29
Operating Profit (PBDIT) excl Other Income
-34.4
28.2
-63.8
-19.7
-8.8
125.9
-5.699999999999999
Other Income
23.27
19.22
30.77
48.10
27.96
40.98
30.72
Operating Profit (PBDIT)
-30.13
2.89
0.45
31.14
24.63
161.21
86.09
Interest
0.31
0.38
0.33
0.28
0.56
0.67
0.63
Exceptional Items
319.37
305.34
67.94
44.39
70.43
68.51
72.68
Gross Profit (PBDT)
73.08
131.23
43.97
75.12
78.47
210.95
105.74
Depreciation
0.00
46.93
46.75
42.09
41.71
40.95
41.21
Profit Before Tax
288.94
260.92
21.31
33.16
52.80
188.10
116.93
Tax
19.98
22.74
-0.29
11.79
8.84
32.37
10.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
268.97
238.18
21.61
21.38
43.96
156.14
108.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
268.97
238.18
21.61
21.38
43.96
156.14
108.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.01
0.00
0.00
0.00
-0.00
-0.41
-1.57
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
268.96
238.18
21.61
21.38
43.96
155.73
106.63
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.13
1.11
1.09
1.1
1.07
1.06
1.11
Reserves
9,711.17
9,272.48
8,875.80
8,878.92
8,699.92
8,597.58
8,859.47
Earnings per share (EPS)
0.37
0.32
0.03
0.03
0.06
0.21
0.14
Diluted Earnings per share
0.37
0.32
0.03
0.03
0.06
0.21
0.14
Operating Profit Margin (Excl OI)
-14.97%
-8.57%
-22.29%
-14.36%
-14.66%
10.73%
2.68%
Gross Profit Margin
81.0%
41.72%
19.69%
18.29%
30.76%
31.0%
29.92%
PAT Margin
75.4%
32.28%
6.25%
5.2%
14.31%
21.13%
20.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 16.11% vs -13.07% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 511.36% vs 114.79% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -1,518.18% vs -126.19% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -50.00% vs -14.29% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of JOINN Laboratories (China) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
356.74
78.83
277.91
352.54%
Other Operating Income
0.00
0.00
0.00
Total Operating income
356.74
78.83
277.91
352.54%
Raw Material Cost
283.65
4.80
278.85
5,809.37%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
15.08
-15.08
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
0.31
0.00
0.31
Selling and Distribution Expenses
85.47
22.24
63.23
284.31%
Other Expenses
2.17
2.86
-0.69
-24.13%
Total Expenditure (Excl Depreciation)
391.09
70.74
320.35
452.86%
Operating Profit (PBDIT) excl Other Income
-34.35
8.09
-42.44
-524.60%
Other Income
23.27
39.93
-16.66
-41.72%
Operating Profit (PBDIT)
-30.13
50.21
-80.34
-160.01%
Interest
0.31
0.00
0.31
Exceptional Items
319.37
-20.34
339.71
1,670.16%
Gross Profit (PBDT)
73.08
74.02
-0.94
-1.27%
Depreciation
0.00
2.19
-2.19
-100.00%
Profit Before Tax
288.94
27.68
261.26
943.86%
Tax
19.98
0.00
19.98
Provisions and contingencies
0
0.00
0.00
Profit After Tax
268.97
27.68
241.29
871.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
268.97
27.68
241.29
871.71%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
-0.01
0.00
-0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
268.96
27.68
241.28
871.68%
Equity Capital
0
0
0.00
Face Value
1.13
0.00
0.00
Reserves
9,711.17
976.88
8,734.29
894.10%
Earnings per share (EPS)
0.37
0.02
0.35
1,750.00%
Diluted Earnings per share
0.37
0.02
0.35
1,750.00%
Operating Profit Margin (Excl OI)
-14.97%
10.26%
0.00
-25.23%
Gross Profit Margin
81.00%
37.89%
0.00
43.11%
PAT Margin
75.40%
35.11%
0.00
40.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 35.67 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -51.66% vs 113.45% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16.11% vs -13.07% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 26.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 12.93% vs 1,002.78% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 511.36% vs 114.79% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -5.34 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -227.61% vs 46.20% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -1,518.18% vs -126.19% in Mar 2025

Quarterly - Interest
Interest 0.03 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -25.00% vs 33.33% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -50.00% vs -14.29% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -14.97%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025